Chronic kidney disease: global dimension and perspectives (Q34347984)

1 August 2017

Chronic kidney disease: global dimension and perspectives (English)

1 reference

chronic renal insufficiency

1 August 2017

1 reference

Vivekanand Jha

1

0 references

author name string

Guillermo Garcia-Garcia

2

1 reference

1 August 2017

Kunitoshi Iseki

3

1 reference

1 August 2017

Zuo Li

4

1 reference

1 August 2017

Saraladevi Naicker

5

1 reference

1 August 2017

Brett Plattner

6

1 reference

1 August 2017

Rajiv Saran

7

1 reference

1 August 2017

Angela Yee-Moon Wang

8

1 reference

1 August 2017

Chih-Wei Yang

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

31 May 2013

1 reference

1 August 2017

1 reference

1 August 2017

382

1 reference

1 August 2017

260-272

1 reference

1 August 2017

9888

1 reference

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

1 reference

7 January 2021

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Mortality from diabetic renal disease: a hidden epidemic.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

How can we achieve global equity in provision of renal replacement therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Current status of chronic kidney disease care in southeast Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Sexual dysfunction in female hemodialysis patients: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Renal function and cardiovascular risk markers in a remote Australian Aboriginal community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

What do we know about chronic kidney disease in India: first report of the Indian CKD registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Prevalence of chronic kidney disease in China: a cross-sectional survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Burden of chronic kidney disease: an international perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

End-stage renal care in developing countries: the India experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Epidemiological transition and the double burden of disease in Accra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Genetic variation in APOL1 associates with younger age at hemodialysis initiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Revised equations for estimated GFR from serum creatinine in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The impact of different GFR estimating equations on the prevalence of CKD and risk groups in a Southeast Asian cohort using the new KDIGO guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Evaluation of GFR measurement method as an explanation for differences among GFR estimation equations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Prevalence of chronic kidney disease in the Japanese general population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Distribution of reference GFR in a development population: a critical factor for the establishment of a GFR estimation equation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Hypertension in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Prevalence and incidence of hypertension from 1995 to 2005: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Obesity and socioeconomic status in developing countries: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Natural medicines causing acute kidney injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Aristolochic acid nephropathy: variation in presentation and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Fifty years of Balkan endemic nephropathy: challenges of study using epidemiological method

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Aristolochic acid nephropathy: a worldwide problem

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Collapsing glomerulopathy in an HIV-positive patient in a low-incidence belt

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Community-acquired acute kidney injury in tropical countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Chronic kidney disease of unknown aetiology in Sri Lanka: is cadmium a likely cause?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Patient awareness of chronic kidney disease: trends and predictors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Epidemiology, impact and preventive care of chronic kidney disease in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Prevalence and risk factors associated with chronic kidney disease in a Uygur adult population from Urumqi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

High prevalence and associated risk factors for impaired renal function and urinary abnormalities in a rural adult population from southern China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

CKD awareness and blood pressure control in the primary care hypertensive population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Awareness of kidney disease and relationship to end-stage renal disease and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Chronic kidney disease and mortality risk: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The importance of residual renal function in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The risk of acute renal failure in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The severity of acute kidney injury predicts progression to chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: The Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The impact of CKD identification in large countries: the burden of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Estimating the financial cost of chronic kidney disease to the NHS in England

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Economics of dialysis and renal transplantation in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Chronic kidney disease epidemic: cost and health care implications in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The clinical and cost-effectiveness of the BRinging Information and Guided Help Together (BRIGHT) intervention for the self-management support of people with stage 3 chronic kidney disease in primary care: study protocol for a randomized controlled t

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Screening for proteinuria in US adults: a cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of r

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Population based screening for chronic kidney disease: cost effectiveness study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

The changing patterns of chronic kidney disease: the need to develop strategies for prevention relevant to different regions and countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Primary health care strategies for the prevention of end-stage renal disease in Cuba

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Improving the management of chronic kidney disease in Uruguay: a National Renal Healthcare Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Risk factors and prevention of end stage renal disease in uruguay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Addressing the global shortage of nephrologists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960687-X

7 January 2021

10.1016/S0140-6736(13)60687-X

Identifiers

DOI

1 reference

1 August 2017

1 reference